1. |
Man WD, Moxham J, Polkey MI. Magnetic stimulation for the measurement of respiratory and skeletal muscle function. Eur Respir J, 2004, 24: 846-860.
|
2. |
王曾礼. 更新对慢性阻塞性肺疾病认识的观念. 中国呼吸与危重监护杂志, 2007, 6: 401-402.
|
3. |
白冲. 慢性阻塞性肺疾病的危险因素、流行情况及未来发展趋势. 中国呼吸与危重监护杂志,2007, 6: 403-405.
|
4. |
Schols AM. Nutritional and metabolic modulation in chronic obstructive pulmonary disease management. Eur Respir J Suppl, 2003, 46: 81s-86s.
|
5. |
杨天芸, 徐卫国, 罗勇, 等. 慢性阻塞性肺病大鼠骨骼肌蛋白降解的变化. 上海交通大学学报( 医学版) , 2008, 28: 525-527.
|
6. |
Creutzberg EC, Schols AM, Weling-Scheepers CA, et al. Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2000, 161: 745-752.
|
7. |
·439· ? 2002-2009 Editorial Department of Chinese Journal of Respiratory and Critical Care Medicine. All rights reserved. Http://www.cjrccm.com 3: 124-125.
|
8. |
李红梅, 崔德健, 佟欣, 等. 熏香烟加气管注内毒素和单纯熏香烟法建立大鼠COPD 模型. 中国病理生理杂志, 2002, 18: 808-812.
|
9. |
Celli BR, MacNee W, ATS /ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS /ERS position paper. Eur Respir J, 2004, 23: 932-946.
|
10. |
姚婉贞, 陈亚红.
|
11. |
, No.
|
12. |
Jagoe RT, Engelen MP. Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease. Eur Respir J Suppl, 2003, 46: 52s-63s.
|
13. |
Rutten EP, Franssen FM, Engelen MP, et al. Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease. Am J Clin Nutr, 2006, 83: 829-834.
|
14. |
Bargon J, Müller U, Buhl R. COPD, a systemic disease--nutritional approaches. Med Klin( Munich) , 2004, 99: 719-726.
|
15. |
高福生, 潘全, 李淑兰, 等. 慢性阻塞性肺疾病患者营养状态对运动耐力及通气氧耗的影响. 中国呼吸与危重监护杂志, 2004, 中国呼吸与危重监护杂志2009 年9 月第8 卷第5 期Chin J Respir Crit Care Med, September 2009, Vol.
|
16. |
Gao M, Karin M. Regulating the regulators: control of protein ubiquitination and ubiquitin-like modifications by extracellular stimuli. Mol Cell, 2005, 19: 581-593.
|
17. |
Taillandier D, Combaret L, Pouch MN, et al. The role of ubiquitinproteasome- dependent proteolysis in the remodelling of skeletal muscle. Proc Nutr Soc, 2004, 63: 357-361.
|
18. |
McKinnell IW, Rudnicki MA. Molecular mechanisms of muscle atrophy. Cell, 2004, 119: 907-910.
|
19. |
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 - △△ Ct method. Methods, 2001, 25: 402-408.
|
20. |
Adams V, Mangner N, Gasch A, et al. Induction of MuRF1 is essential for TNF-alpha-induced loss of muscle function in mice. J Mol Biol, 2008, 384: 48-59.
|
21. |
Schols AM. Pulmonary cachexia. Int J Cardiol, 2002, 85: 101-110.
|
22. |
Van Helvoort HA, Heijdra YF, Thijs HM, et al. Exercise-induced systemic effects in muscle-wasted patients with COPD. Med Sci Sports Exerc, 2006, 38: 1543-1552.
|
23. |
Sevenoaks MJ, Stockley RA. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype? Respir Res, 2006, 7 : 70 .
|
24. |
Eid AA, Ioneseu AA, Nixon LS. Inflammatory Response and Body Composition in Chronic Obstructive Pulmonary Disease. AmJRespir Crit Care Meel Vol, 2001, 164: 1414-1418.
|
25. |
徐卫国, 罗勇, 吴靖川, 等. 不同营养状态COPD 肿瘤坏死因子- α测定及其临床意义. 中国实用内科杂志, 1999, 19: 654-655.
|
26. |
Ryther RCC, Flynt AS, Phillips 3rd JA, et al. siRNA therapeutics: big potential from small RNAs. Gene Ther, 2005, 12: 5-11.
|
27. |
Tisdale MJ. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol, 2005, 3: 209-217.
|
28. |
年欧洲呼吸学会年会慢性阻塞性肺疾病研究进展. 中国呼吸与危重监护杂志, 2004, 3: 413-415.
|